SETD2 and nonpapillary renal cell carcinoma: SETD2 is one of the most frequently mutated chromatin-modifying genes across different cancer types, with the highest mutation rate in clear cell renal cell carcinoma (ccRCC, 13%) followed by lung adenocarcinoma (9%) (11, 12).